Related Experiment Video
Updated: Dec 29, 2025

Use of a Hanging-weight System for Isolated Renal Artery Occlusion
Published on: July 19, 2011
Citrate-Based Self-Circulation Anticoagulation Protocol for Discontinuity of Continuous Renal Replacement Therapy
Yonglin Weng1, Fang Zhou1, Yueqiang Fu1
1Intensive Care Unit, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Children Development and Disorders, International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China.
Insights
Citrate self-circulation anticoagulation protocol (CSAP) offers a safe and effective method to maintain continuous renal replacement therapy (CRRT) in critically ill children during treatment interruptions. This approach ensures continuity without compromising patient safety or altering key physiological parameters.
Area of Science:
- Pediatric Nephrology
- Critical Care Medicine
- Pharmacology
Background:
- Continuous renal replacement therapy (CRRT) is vital for critically ill children but often requires interruption for procedures.
- Discontinuities in CRRT can disrupt treatment efficacy and patient stability.
Purpose of the Study:
- To evaluate a citrate self-circulation anticoagulation protocol (CSAP) for maintaining CRRT continuity during treatment interruptions in pediatric patients.
- To assess the safety and feasibility of CSAP in this vulnerable population.
Main Methods:
- A prospective observational study involving 57 pediatric patients and 88 CRRT sessions.
- CSAP was implemented using a specific sodium citrate and saline regimen during treatment gaps.
- In-line pressures, blood counts, electrolytes, and blood gas parameters were monitored before, during, and after CSAP.
Main Results:
- CSAP averaged 118.5 minutes without significant changes in arterial, venous, or transmembrane pressures.
- No significant decrease in blood cell counts was observed during CSAP.
- Key electrolyte levels (calcium ratio, Na+, HCO3-) and pH remained stable throughout CSAP.
Conclusions:
- Citrate self-circulation anticoagulation protocol (CSAP) is a safe and effective strategy for managing CRRT discontinuity in pediatric critical care.
- CSAP provides a feasible solution to maintain treatment continuity, minimizing disruptions and ensuring patient stability.
Background/Aims:
Continuous renal replacement therapy (CRRT) has been used widely in the treatment of critically ill children for its continuity. However, sometimes we have to interrupt the continuity for necessary surgeries or blood transfusions. Our objective was to demonstrate a feasible self-circulation anticoagulation protocol based on citrate (CSAP) to address discontinuity during CRRT.
Methods:
We conducted a prospective observational study of 57 pediatric patients undergoing 88 CRRT sessions that were receiving CSAP during the treatment discontinuity period by using an anticoagulation regimen containing 5 mL 4% sodium citrate in 50 mL of saline to maintain the continuity. We documented the reasons for CSAP and the total duration of the treatment. We assessed the in-line pressure recordings, blood routine examination, blood electrolytes, and blood gas analysis before, throughout, and after the period of CSAP.
Results:
The average duration of CSAP was 118.5 ± 45.3 min. There was no significant increase in arterial pressures, venous pressures, and transmembrane pressures and no significant decreases in blood cell counts observed at the end of the CSAP, compared to the data recorded at the beginning of the CSAP. Compared to before the CSAP, there was no significant change in the ratio of total to ionized calcium, Na+, HCO3-, and pH value after CSAP.
Conclusions:
CSAP might be a safe, effective, and easy approach for use during the treatment discontinuity of CRRT in children.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Venous Thrombosis III: Interprofessional Care
Hemodialysis II: Procedure and Complications

